Burning feet, tingling hands, and persistent numbness are more than minor discomforts. For people living with peripheral neuropathy, these symptoms can turn everyday activities such as walking, exercising, sleeping, and even wearing shoes into daily challenges. Traditional treatments often focus on managing pain, but growing research into photobiomodulation therapy (PBMT) is examining how targeted light energy may help address some of the biological processes associated with nerve pain.

From diabetic peripheral neuropathy to chemotherapy-related nerve damage, laser therapy is attracting attention as a potential complementary approach to neuropathy management. But how does it work, and what does clinical research actually reveal?

1. Why Do Your Feet Burn and Hands Tingle? Understanding Peripheral Neuropathy

1.1 What Is Peripheral Neuropathy? Common Symptoms of Nerve Damage

Peripheral neuropathy refers to damage or dysfunction affecting the peripheral nervous system—the network of nerves connecting the brain and spinal cord to the rest of the body. These nerves transmit sensory information, control muscle movement, and regulate certain automatic body functions.

When peripheral nerves become damaged, their ability to transmit signals correctly can be disrupted. Common peripheral neuropathy symptoms include burning feet, tingling hands, numbness, pins-and-needles sensations, electric-shock-like pain, and increased sensitivity to touch.

Some patients experience muscle weakness, poor coordination, or balance problems. Symptoms often begin in the toes and feet before gradually affecting the legs and, in some cases, the hands. This pattern is particularly common in length-dependent peripheral neuropathy.

1.2 What Causes Peripheral Neuropathy?

There are several possible causes of nerve damage. Diabetes is one of the leading causes of peripheral neuropathy. Persistently elevated blood glucose can contribute to oxidative stress, metabolic dysfunction, and damage to the small blood vessels that support peripheral nerves.

Other causes include chemotherapy medications, excessive alcohol consumption, vitamin B12 deficiency, autoimmune conditions, infections, and physical nerve compression. In some cases, doctors cannot identify a specific underlying cause, resulting in a diagnosis of idiopathic peripheral neuropathy.

Identifying the cause is essential because effective treatment depends on the underlying condition. For example, managing blood glucose is a critical part of diabetic neuropathy care, while correcting a confirmed vitamin deficiency may help prevent further nerve damage.

1.3 Why Does Neuropathy Pain Get Worse at Night?

Many people report that neuropathy pain becomes more noticeable at night. Burning sensations, tingling, and shooting nerve pain can make it difficult to fall asleep or remain comfortable.

One explanation involves abnormal electrical signaling in damaged nerves. Injured sensory nerves may become unusually excitable, generating spontaneous signals that the brain interprets as pain, even without an obvious external stimulus.

At night, fewer environmental distractions may also make these sensations more noticeable. Persistent discomfort can interfere with sleep quality, reduce physical activity, and affect overall quality of life.

2. Beyond Painkillers: How Photobiomodulation Therapy Targets Peripheral Nerve Damage

2.1 How Does Laser Therapy Work for Neuropathy?

Photobiomodulation Therapy (PBMT) uses specific wavelengths of red and near-infrared light to interact with biological tissues and influence cellular activity. It includes low-level laser therapy (LLLT), commonly used in non-thermal light-based applications.

One proposed mechanism involves cytochrome c oxidase, an enzyme within mitochondria that plays an important role in cellular energy production. Light absorption may influence mitochondrial activity, adenosine triphosphate (ATP) production, nitric oxide signaling, and oxidative stress.

These processes are relevant because nerve cells require substantial energy to maintain normal function and respond to injury. PBM research also suggests potential effects on inflammatory signaling and cellular stress responses.

In a 2017 review published in AIMS Biophysics, Professor Michael R. Hamblin examined the anti-inflammatory mechanisms of photobiomodulation, including its potential influence on inflammatory mediators and cellular pathways. This research provides a scientific foundation for investigating PBM in pain management and tissue recovery.

2.2 Can Laser Therapy Reduce Nerve Pain?

Peripheral neuropathy involves more than physical nerve damage. Changes in inflammatory activity, local circulation, and abnormal sensory signaling may also contribute to persistent discomfort.

Photobiomodulation is being investigated for its potential to influence these processes. Research suggests that red and near-infrared light may help regulate inflammatory responses, support local microcirculation, and modulate pain-related biological pathways.

A study by Yamany and Sayed (2012), published in the Journal of Advanced Research, investigated low-level laser therapy and neurovascular function in patients with diabetic peripheral neuropathy.

Although these mechanisms are promising, it is important to distinguish symptom relief from nerve regeneration. Reduced burning or tingling does not necessarily mean that damaged nerve fibers have been structurally repaired.

2.3 Red Light vs. Near-Infrared Laser Therapy: Which Wavelengths Reach Peripheral Nerves?

Different wavelengths interact with tissue differently. Red light, commonly around 630–660 nm, is generally associated with more superficial tissue applications, while near-infrared wavelengths such as 810–980 nm are commonly investigated for applications involving deeper tissues.

However, wavelength alone does not determine treatment effectiveness. Power density, energy density, exposure time, treatment location, and tissue characteristics all influence the delivered dose.

Laser and LED devices should also not be considered identical. Both can deliver therapeutic light, but their optical characteristics, beam distribution, power density, and treatment configurations may differ considerably.

Combining appropriate red and near-infrared wavelengths is therefore an area of interest in photobiomodulation research, particularly for conditions involving both superficial and deeper tissue structures.

3. What Do Clinical Studies Reveal? Real Research on Laser Therapy for Diabetic Peripheral Neuropathy

3.1 A Randomized Clinical Study of 60 Patients: Can 630nm and 810nm Laser Therapy Improve Neuropathy Symptoms?

A 2023 randomized controlled study published in the Journal of Lasers in Medical Sciences investigated photobiomodulation in 60 patients with diabetic peripheral neuropathy.

Participants were divided into two groups. The laser group received conventional medication combined with 630nm and 810nm low-level laser therapy, while the control group received conventional treatment alone.

The laser treatment was administered for 15 minutes per session, three times weekly, over 12 sessions.

Researchers evaluated participants using the Michigan Neuropathy Screening Instrument (MNSI) and monofilament testing. The study reported statistically significant improvements in selected neuropathy questionnaire results and foot sensation measurements in the laser group.

For example, the number of patients demonstrating sensation in the right-foot monofilament assessment increased from 22 to 26, while the corresponding left-foot result increased from 20 to 25.

These findings suggest that combining red and near-infrared laser therapy with conventional treatment may help improve selected neuropathy symptoms. However, the study was relatively small, and not every MNSI assessment showed a significant difference.

3.2 A 2026 Double-Blind Clinical Trial: Did Laser Therapy Reduce Burning Foot Pain?

More recent evidence comes from a 2026 randomized, double-blind, sham-controlled trial published in Pain Research and Management.

The study included 64 adults with painful diabetic peripheral neuropathy, divided into an active-treatment group of 33 participants and a sham-control group of 31.

After three weeks of twice-daily treatment, 72.7% of participants receiving active laser therapy achieved at least a 30% reduction in foot pain, compared with 32.3% in the sham group.

The mean pain reduction was 33.4 points in the active-treatment group, compared with 20.0 points in the control group.

Researchers also reported improvements in burning pain and abnormal sensory sensations. Some benefits remained observable four weeks after treatment ended.

This study is particularly important because a sham-controlled design helps distinguish treatment effects from expectations and other nonspecific influences. Nevertheless, the findings demonstrate short-term pain relief rather than a cure for diabetic neuropathy. The study was also industry-sponsored, which is relevant when evaluating its results.

3.3 A 2026 Pilot Study: What About Numbness and Neuropathic Pain?

Another randomized pilot trial, published in Lasers in Medical Science in July 2026, investigated PBMT with or without intravascular laser irradiation of blood (ILIB).

The study included 26 participants divided into local PBMT, combined PBMT and ILIB, and sham-control groups. All participants completed 12 treatment sessions over 23 days.

Across the study population, reported neuropathy symptoms improved. The proportion of participants reporting numbness decreased from 61.5% to 26.9%, while leg and foot cramps decreased from 73.1% to 11.5%.

The local PBMT group also showed a reduction in neuropathic pain scores. However, this was a small exploratory study, and improvements within a treatment group should not automatically be interpreted as proof of superiority over sham treatment.

Together, these clinical studies provide encouraging evidence that photobiomodulation deserves further investigation as a complementary approach to diabetic neuropathy management.

4. Can Laser Therapy Help Different Types of Peripheral Neuropathy?

4.1 Laser Therapy for Diabetic Neuropathy

Diabetic peripheral neuropathy is closely associated with prolonged high blood glucose, oxidative stress, and impaired microvascular function. These factors can gradually affect nerve health, particularly in the feet and lower legs.

PBMT may offer complementary support by influencing inflammatory responses and cellular activity. Combined with blood glucose management and conventional medical treatment, it is a promising area of clinical investigation.

4.2 Laser Therapy for Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) can cause numbness, tingling, burning sensations, and reduced sensation in the hands and feet. Certain chemotherapy drugs can damage peripheral sensory nerves, sometimes leaving patients with persistent symptoms after treatment.

Emerging research is investigating photobiomodulation as a potential approach to managing CIPN symptoms. However, further clinical trials are needed before laser therapy can be considered an established treatment for chemotherapy-related nerve damage.

4.3 Laser Therapy for Idiopathic Peripheral Neuropathy

Some patients develop peripheral neuropathy without an identifiable underlying cause. This condition is known as idiopathic peripheral neuropathy.

Although PBM may have potential applications in managing associated pain and discomfort, identifying possible underlying causes remains essential. A comprehensive treatment plan should be guided by appropriate neurological evaluation.

5. Laser Therapy for Peripheral Neuropathy: Treatment Protocols and Recovery Expectations

5.1 What Is the Best Laser Therapy Protocol for Neuropathy?

Effective laser treatment depends on several technical factors, including wavelength, power density, energy density (J/cm²), treatment duration, and application location.

Clinical research has investigated wavelengths such as 630nm, 660nm, and 810nm for diabetic neuropathy. However, there is currently no universally established laser protocol for every type of peripheral neuropathy.

Treatment parameters should be selected according to the device, clinical evidence, and individual patient needs.

5.2 How Long Does Laser Therapy Take to Work for Nerve Pain?

Recovery varies depending on the severity of nerve damage, underlying medical conditions, and treatment protocols.

Clinical studies have reported improvements following treatment courses lasting several weeks. Some patients may experience changes in pain or sensory symptoms, while others may require longer-term management.

It is also important to understand that reducing neuropathic pain and restoring damaged nerve function are two different outcomes. Consistent follow-up helps healthcare professionals evaluate treatment responses.

5.3 Can Laser Therapy Be Combined With Conventional Neuropathy Treatment?

Laser therapy is best considered a complementary approach rather than a replacement for established neuropathy care.

A comprehensive treatment strategy may include:

• Blood glucose management for diabetic neuropathy.
• Physician-directed medication for neuropathic pain.
• Physical therapy and appropriate exercise.
• Nutritional assessment and correction of confirmed deficiencies.
• Regular neurological assessments and diabetic foot care.

Combining appropriate medical management with emerging non-pharmacological approaches may help patients address different aspects of peripheral neuropathy.

Peripheral neuropathy can significantly affect daily life, turning ordinary activities into persistent challenges. While conventional treatments primarily focus on managing symptoms and underlying causes, photobiomodulation therapy offers another promising area of research.

Clinical studies involving 630nm and 810nm laser wavelengths have reported improvements in selected neuropathy symptoms and reductions in diabetic foot pain. Although further large-scale research is necessary, these findings highlight the potential role of laser therapy in complementary nerve pain management.

For patients experiencing burning feet, tingling hands, or persistent numbness, laser therapy represents an emerging approach worth discussing with a qualified healthcare professional.